Skip to content

Clinical trials

Non-alcoholic Fatty Liver Disease trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Country / region: Russia Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20121
20163
20172
20181
20192
20202
20214
20221
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated6
Active, not recruiting2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Novo Nordisk A/S3
Federal State Budgetary Scientific Institution2
Merck Sharp & Dohme LLC2
Abbott1
Genfit1
GlaxoSmithKline1
I.M. Sechenov First Moscow State Medical University1
National Medical Research Center for Therapy and Preventive Medicine1
POLYSAN Scientific & Technological Pharmaceutical Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease19
Fatty Liver5
Diabetes Mellitus, Type 23
Liver Cirrhosis3
Liver Diseases2
Acquired Immunodeficiency Syndrome1
Asthma1
Digestive System Diseases1
Fatty Liver, Alcoholic1
Fibrosis1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.